Dr. Lucky Tran Jul 23, 2024

A new drug described as “the closest we have ever been to an HIV vaccine” could be sold for $40 a year and still make 30% profit, but is currently being sold by pharma companies for $42,250. Absolutely criminal.

https://www.theguardian.com/global-development/article/2024/jul/23/hiv-aids-prevention-vaccine-lenacapavir-sunlenca-pharmaceuticals-gilead-generic-licensing

HIV drug could be made for just $40 a year for every patient

Generic version of a drug already on the market, which can suppress and prevent HIV, would still yield 30% profit if the current price was slashed, researchers say

The Guardian
Show threadDeus
@luckytran

The headline of this article was amended on 23 July 2024 to reflect that, although the lead researcher said it was “as close as we’ve ever been to an HIV vaccine”, lenacapavir is a drug rather than a vaccine.

Jul 24, 2024 at 12:42amWeb